(Q45172325)

English

A routine method for the quantification of the novel antimycotic drug posaconazole in plasma using liquid chromatography-tandem mass spectrometry

scientific article published in January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

A routine method for the quantification of the novel antimycotic drug posaconazole in plasma using liquid chromatography-tandem mass spectrometry (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

author name string

Michael Vogeser

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Christina Rieger

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Helmut Ostermann

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Ute Spöhrer

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Clinical Chemistry and Laboratory Medicine

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

579-584

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

describes a project that uses

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Antifungal prophylaxis for invasive mycoses in high risk patients

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Posaconazole: an extended-spectrum triazole antifungal agent

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

A decade of HPLC-MS/MS in the routine clinical laboratory--goals for further developments

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Use of high-performance liquid chromatographic and microbiological analyses for evaluating the presence or absence of active metabolites of the antifungal posaconazole in human plasma

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Disposition of posaconazole following single-dose oral administration in healthy subjects

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Quantification of sirolimus by liquid chromatography-tandem mass spectrometry using on-line solid-phase extraction

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Determination of itraconazole and hydroxyitraconazole in plasma by use of liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.129

21 January 2018

Identifiers

10.1515/CCLM.2009.129

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45172325&oldid=2145795997"